Rasby 1.5mg Injection is an antihyperuricemic drug belonging to the category of uricolytic agents.
The active ingredient is Rasburicase.
It is used in the treatment of acute hyperuricemia in patients receiving chemotherapy.
Uses:
Treating high uric acid levels in patients undergoing chemotherapy.
Preventing or treating hyperuricemia in patients with tumor lysis syndrome.
Therapeutic Effects:
Converts uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys.
Reduces the levels of uric acid in the blood and prevents the development of hyperuricemia.
Interaction with Other Drugs:
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Rasby 1.5mg Injection and reduce effectiveness by causing undesirable side effects.
Safety Advice:
Pregnancy: It is unsafe to use during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Breastfeeding: It is not known if Rasby 1.5mg Injection passes into breast milk. Please consult your doctor before breastfeeding.
Lungs: It is unknown whether Rasby 1.5mg Injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Liver: It is unknown whether Rasby 1.5mg Injection can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment.
Alcohol: Consuming alcohol may affect the effectiveness of Rasby 1.5mg Injection. Stop consuming alcohol if you are taking this medicine.
Driving: It is unsafe to drive vehicles or operate heavy machinery after taking the Rasby 1.5mg Injection because it contains a small amount of alcohol which may cause dizziness and impair your concentration.
Side Effects:
Serious: Swelling of face, lips, tongue; wheezing and breathing problems.
Common: Nausea, vomiting; fever; swelling; anxiety; headache; abdominal pain; constipation; diarrhea; low phosphate levels in the blood; high levels of liver enzymes in the blood; rashes.
Word of Advice:
Avoid foods that are high in purines, such as red meat, organ meats, and some seafood, which can increase uric acid levels and reduce the effectiveness of Rasby 1.5mg Injection.
Avoid driving and operating heavy machinery if you feel tired or weak during this treatment.
Avoid activities or conditions that can trigger gout attacks, such as fasting, rapid weight loss, and stress.
Drink plenty of fluids, especially water, while taking this medicine.
Avoid smoking or using tobacco products while undergoing treatment with Rasby 1.5mg Injection.
FAQs:
What is the purpose of Rasby 1.5mg Injection?
Rasby 1.5mg Injection is used to prevent or treat hyperuricemia (high levels of uric acid in the blood) in patients who are undergoing cancer chemotherapy for leukemia, lymphoma, and solid tumor malignancies.
Is Rasby 1.5mg Injection supportive therapy?
Yes, it is an important supportive therapy for patients undergoing chemotherapy to reduce the risk of complications associated with high levels of uric acid in the blood.
Who should not use Rasby 1.5mg Injection?
Rasby 1.5mg Injection are not indicated for those who have already developed acute gout or hyperuricemia due to conditions other than cancer chemotherapy.
What should I avoid while taking Rasby 1.5mg Injection?
It is advised to avoid certain medications, such as allopurinol, which is used to lower uric acid levels. Using allopurinol with Rasby 1.5mg injection together can reduce the effectiveness of rasburicase.
How does Rasby 1.5mg Injection work?
Rasby 1.5mg Injection works by converting uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys. This reduces the levels of uric acid in the blood and prevents the development of hyperuricemia.
Does Rasby 1.5mg Injection help to protect people who are at high risk for tumor lysis syndrome (TLS)?
Yes, it is often used prophylactically in individuals who are at high risk for TLS due to their cancer chemotherapy.
Fact Box:
Molecule name: Rasburicase Injection.
Therapeutic class: Antihyperuricemic.
Pharmacological class: Uricolytic agent.
Indications: Treat high uric acid levels in chemotherapy.
